Vertex Pharmaceuticals Inc.

VRTX NMS
Pharmaceuticals
Boston, MA
2016 Revenue (US$ Millions)$1,702
Revenue Growth (%)64.89%
2015 Revenue (US$ Millions)$1,032
Net Income (US$ Millions)($112)
Common Shares Outstanding (Millions)248.3
Earnings Per Share (US$)($0.46)
Price to Earnings RatioN/A
Total Equity (US$ Millions)$1,157
Return on Equity (%)-11.92%
Long Term Debt (US$ Millions)$521
Debt to Equity Ratio (%)0.45%
Market Capitalization (US$ Millions)$18,292
Total Assets (US$ Millions)$2,897
Current Assets (US$ Millions)$1,832
Inventories (US$ Millions)$78
Current Liabilities (US$ Millions)$793
Cost Of Goods Sold (US$ Millions)$207
Asset Turnover0.63
Inventory Turnover3.07